Bluejay Diagnostics (BJDX) Shares Outstanding (Diluted) (2021 - 2026)
Bluejay Diagnostics (BJDX) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 386.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 577.60 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 390.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 454.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 968.57 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 97.90 Mn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | 2.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 984,668.00 |
| Mar 31, 2026 | 984,668.00 |
| Dec 31, 2025 | 449,043.00 |
| Sep 30, 2025 | 393,634.00 |
| Jun 30, 2025 | 346,780.00 |
| Mar 31, 2025 | 138,503.00 |
| Dec 31, 2024 | 45,848.00 |
| Sep 30, 2024 | 47,779.00 |
| Jun 30, 2024 | 2,416.00 |
| Mar 31, 2024 | 1,475.00 |
| Dec 31, 2023 | 685.00 |
| Sep 30, 2023 | 689.00 |
| Jun 30, 2023 | 639.00 |
| Mar 31, 2023 | 637.00 |
| Dec 31, 2022 | 630.00 |
| Sep 30, 2022 | 630.00 |
| Jun 30, 2022 | 630.00 |
| Mar 31, 2022 | 629.00 |
| Dec 31, 2021 | 266.00 |
| Sep 30, 2021 | 328.00 |